№5 2018 тп
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
ПОВОЛЖСКИЙ<br />
ОНКОЛОГИЧЕСКИЙ<br />
ВЕСТНИК<br />
2. Blann A.D., Dunmore S. Arterial and venous<br />
thrombosis in cancer patients // Cardiol. Res. Pract. —<br />
2011. — Vol. 2011, Article ID: 394740. — 11 p.<br />
3. Mezouar S., Frère C., Darbousset R. et al. Role of<br />
platelets in cancer and cancer-associated thrombosis:<br />
experimental and clinical evidences // Thromb Res. —<br />
2016. — Vol. 139. — P. 65-76.<br />
4. Pavo N., Raderer M., Hülsmann M. et al. Cardiovascular<br />
biomarkers in patients with cancer and their<br />
association with allcause mortality // Heart. — 2015. —<br />
Vol. 101, №23. — P. 1874-1880.<br />
5. Herrmann J., Lerman A. The endothelium: dysfunction<br />
and beyond // J. Nucl Cardiol. — 2001. — Vol. 8, №2. —<br />
P. 197-206.<br />
6. Herrmann J., Lerman A. The endothelium — the<br />
cardiovascular health barometer // Herz. — 2008. —<br />
Vol. 33, <strong>№5</strong>. — P. 343-353.<br />
7. Yusuf S.W., Daraban N., Abbasi N. et al. Treatment and<br />
outcomes of acute coronary syndrome in the cancer<br />
population // Clin. Cardiol. — 2012. — Vol. 35, №7. —<br />
P. 443-450.<br />
8. Mohanty D.B., Mohanty S., Hussain Y et al. Management<br />
of ischemic coronary disease in patients receiving<br />
chemotherapy: an uncharted clinical challenge //<br />
Future Cardiol. — 2017. — Vol. 13, №3. — P. 247-257.<br />
9. Vieira R.D., Pereira A.C., Lima E.G. et al. Cancer-related<br />
deaths among different treatment options in chronic<br />
coronary artery disease: results of a 6-year follow-up<br />
of the MASS II study // Coron Artery Dis. — 2012. —<br />
Vol. 23, №2. — P. 79-84.<br />
10. Ibanez B., James S., Agewall S. et al. ESC Guidelines<br />
for the management of acute myocardial infarction in<br />
patients presenting with ST-segment elevation: The<br />
Task Force for the management of acute myocardial<br />
infarction in patients presenting with ST-segment<br />
elevation of the European Society of Cardiology (ESC) //<br />
Eur. Heart J. — <strong>2018</strong>. — Vol. 39, №2. — P. 119-177.<br />
11. Hamon M., Rasmussen L.H., Manoukian S.V. et<br />
al. Choice of arterial access site and outcomes in<br />
patients with acute coronarysyndromes managed<br />
with an early invasive strategy: The ACUITY trial //<br />
EuroIntervention. — 2009. — Vol. 5, №1. — P. 115-120.<br />
12. Sciahbasi A., Fischetti D., Picciolo A., et al. Transradial<br />
access compared with femoral puncture closure<br />
devices in percutaneous coronary procedures // Int. J.<br />
Cardiol. — 2009. — Vol. 137. — P. 199-205.<br />
13. Krishnasamy V.P., Hagar M.J., Scher D.J. et al. Vascular<br />
closuredevices: Technical tips, complications, and<br />
management // Tech. Vasc. Interv. Radiol. — 2015. —<br />
Vol. 18, №2. — P. 100-112.<br />
Том 9, <strong>№5</strong>. <strong>2018</strong><br />
14. Palmerini T., Biondi-Zoccai G., Della Riva D. et al. Clinical<br />
outcomes with drug-eluting and bare-metal stents<br />
in patients with ST-segment elevation myocardial<br />
infarction: evidence from a comprehensive network<br />
meta-analysis // J. Am Coll Cardiol. — 2013. — Vol. 62,<br />
№6. — P. 496-504.<br />
15. Wang F., Gulati R., Lennos Ryan J. et al. Cancer History<br />
Portends Worse Acute and Long-term Noncardiac (but<br />
Not Cardiac) Mortality After Primary Percutaneous<br />
Coronary Intervention for Acute ST-Segment<br />
Elevation Myocardial Infarction // Mayo Clinic Proc. —<br />
2016. — Vol. 91, №12. — P. 1680-1692.<br />
16. Ariotti S., Adamo M., Costa F. et al. Is Bare-Metal<br />
Stent Implantation Still Justifiable in High Bleeding<br />
Risk Patients Undergoing Percutaneous Coronary<br />
Intervention?: A Pre-Specified Analysis From the ZEUS<br />
Trial // JACC Cardiovasc. Interv. — 2016. — Vol. 9, <strong>№5</strong>. —<br />
P. 426-436.<br />
17. Garot P., Morice M.-C., Tresukosol D et al. 2-Year<br />
Outcomes of High Bleeding Risk Patients After<br />
Polymer-Free Drug-Coated Stents // JACC. — 2017. —<br />
Vol. 69, №2. — P. 162-171.<br />
18. Cutlip D.E., Garatt K.N., Novack V et al. 9-Month<br />
Clinical and Angiographic Outcomes of the COBRA<br />
Polyzene-F NanoCoated Coronary Stent System //<br />
JACC Cardiovasc. Interv. — 2017. — Vol. 10, №2. —<br />
P. 160-167.<br />
19. Iliescu C.A., Grines C.L., Herrmann J. et al. SCAI Expert<br />
consensus statement: Evaluation, management, and<br />
special considerations of cardio-oncology patients<br />
in the cardiac catheterization laboratory (endorsed<br />
by the cardiological society of india, and sociedad<br />
Latino Americana de Cardiologıa intervencionista) //<br />
Catheter Cardiovasc. Interv. — 2016. — Vol. 87, <strong>№5</strong>. —<br />
P. 202-223.<br />
20. Elting L.S., Rubenstein E.B., Martin C.G. et al. Incidence,<br />
cost, and outcomes of bleeding and chemotherapy<br />
dose modification among solid tumor patients with<br />
chemotherapyinduced thrombocytopenia // J. Clin.<br />
Oncol. — 2001. — Vol. 19, №4. — P. 1137-1146.<br />
21. Guillem-Llobat P., Dovizio M., Bruno A. et al. Aspirin<br />
prevents colorectal cancer metastasis in mice by<br />
splitting the crosstalk between platelets and tumor<br />
cells // Oncotarget. — 2001. — Vol. 7, №22. —<br />
P. 32462-32477.<br />
22. Padfield G.J., Newby D.E., Mills M.N. Understanding<br />
the role of endothelial progenitor cells in<br />
percutaneous coronary intervention // J. Am. Coll<br />
Cardiol. — 2010. — Vol. 55, №15. — P. 1553-1565.<br />
60<br />
Клинические исследования и опыт в онкологии
Change language